Chemical Compound

N-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]pyrazin-2- yl}methyl)amino]-5- (trifluoromethyl)pyrimidin-2- yl}amino)benzamide (317)

CAS Registry Number 1073154-85-4
N-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]pyrazin-2- yl}methyl)amino]-5- (trifluoromethyl)pyrimidin-2- yl}amino)benzamide (317) 结构式
Primary record

N-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]pyrazin-2- yl}methyl)amino]-5- (trifluoromethyl)pyrimidin-2- yl}amino)benzamide (317)

库存
9,677 克
纯度
99.1 %
CAS
1073154-85-4

化合物标识与属性

CAS
1073154-85-4
PubChem CID
25117126
SMILES
CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F
Canonical SMILES
CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1

名称与同义词

  • Defactinib
  • 1073154-85-4
  • defactinibum
  • Defacitinib
  • VS-6063
  • PF-04554878
  • Defactinib [USAN]
  • Defactinib [USAN:INN]
  • Defactinib hydrochloride
  • DEFACTINIB [INN]
  • Defactinib (USAN/INN)
  • RefChem:919757
  • 53O87HA2QU
  • UNII-53O87HA2QU
  • C20H21F3N8O3S
  • D0V6EV
  • D0Y1UO
  • DEFACTINIB [WHO-DD]
  • MFCD25977806
  • GTPL7910
  • orb1183414
  • orb1306800
  • SCHEMBL1627234
  • CHEMBL3137331
  • FAK inhibitors (cancer), Pfizer
  • Defactinib (PF-04554878)
  • FWLMVFUGMHIOAA-UHFFFAOYSA-N
  • 1345713-71-4
  • BDBM418817
  • DTXSID901025937
  • GLXC-90041
  • HMS3740O13
  • AMY42170
  • AOB87723
  • BCP11299
  • Defactinib (VS-6063, PF-04554878)
  • EX-A1037
  • EX-A1049
  • VS 6063
  • 2-(3-Chloro-phenylsulfanyl)-ethanol
  • 2361AH
  • NSC778364
  • NSC781450
  • NSC782549
  • NSC800089
  • s7654
  • VS6063
  • US10450297, Example 317
  • US10450297, Example 318
  • AKOS026750300
  • N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
  • ZINC103297739
  • CCG-269780
  • CS-3410
  • DB12282
  • NSC-778364
  • NSC-781450
  • NSC-782549
  • NSC-800089
  • SB17060
  • NCGC00386425-06
  • NCGC00386425-11
  • AC-35820
  • AK546976
  • AS-17045
  • BC600623
  • DA-34914
  • DA-45890
  • FD103987
  • HY-12289
  • PF 04554878
  • N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide
  • PF-941222
  • B4800
  • FT-0706351
  • FT-0721609
  • NS00073320
  • PF-4554878
  • J3.502.756D
  • A11929
  • D10618
  • Defactinib (VS-6063, PF-04554878)?
  • A857460
  • A887883
  • Avmapki Fakzynja (avutometinib + defactinib co-pack)
  • BRD-K43578482-001-01-4
  • BRD-K43578482-001-02-2
  • Q27077009
  • Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-
  • B0084-462762
  • N-methyl-4-((4-(((3-methyl(methylsulfonyl)aminopyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
  • ~{N}-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide
  • N-Methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
  • 1073160-26-5
  • 4-[[4-[[3-[Methyl(methylsulfonyl)amino]pyrazin-2-ylmethyl]amino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methylbenzamide
  • 7KD
  • N-methyl-4-((4-(((3-(N-methylmethanesulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
  • N-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]pyrazin-2- yl}methyl)amino]-5- (trifluoromethyl)pyrimidin-2- yl}amino)benzamide (317)
  • N-methyl-4-(4-((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)benzamide
  • N-Methyl-4-[[4-[[[3-[methyl(methylsulfonyl)amino]-2-pyrazinyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]benzamide
  • N-Methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-trifluoromethylpyrimidin-2-yl]amino]benzamide
  • N-METHYL-4-{[4-({[3-(N-METHYLMETHANESULFONAMIDO)PYRAZIN-2-YL]METHYL}AMINO)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}BENZAMIDE